Clinical Trials on Dermatitis, Atopic in New Zealand
Total 614 results
-
Tavotek BiotherapeuticsRecruiting
-
Ribon Therapeutics, Inc.RecruitingAtopic DermatitisAustralia, New Zealand
-
Akesobio Australia Pty LtdCompletedAtopic DermatitisNew Zealand, Australia
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisGermany, New Zealand, Australia
-
AnaptysBio, Inc.RecruitingAtopic Dermatitis EczemaUnited States, Canada, Georgia, New Zealand
-
ShaperonRecruitingAtopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis of ScalpUnited States
-
Akesobio Australia Pty LtdRecruitingPhase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic DermatitisAtopic DermatitisUnited States, Australia, New Zealand
-
University of SouthamptonNational University Hospital, Singapore; Singapore Institute for Clinical Sciences and other collaboratorsEnrolling by invitationNeurobehavioral Manifestations | Allergy | Microbial Colonization | Growth Disorders | Atopic Dermatitis | Obesity, Childhood | Metabolic Disturbance | Cognition | Lifestyle | Breastfeeding | Nutrition, Healthy | AtopySingapore, United Kingdom, New Zealand
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisUnited States, Australia, China, New Zealand
-
Botanix PharmaceuticalsCompletedAtopic DermatitisUnited States, Australia, New Zealand
-
MedImmune LLCAmgenCompletedAtopic DermatitisUnited States, Germany, New Zealand, Hungary, Australia, Canada
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedAtopic Dermatitis (AD)United States
-
Qurient Co., Ltd.CompletedModerate to Severe Atopic DermatitisUnited States
-
Regeneron PharmaceuticalsSanofiCompletedStudy to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)Atopic Dermatitis (AD)United States, Canada
-
Inmagene LLCActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic Dermatitis | ADCanada, United States
-
AmgenCompletedDermatitis, Atopic DermatitisCanada, United States, Japan
-
Regeneron PharmaceuticalsSanofiRecruitingModerate-to-Severe Atopic Dermatitis | Atopic EczemaUnited States
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
National Institute of Allergy and Infectious Diseases...Sanofi; Regeneron Pharmaceuticals; Rho Federal Systems Division, Inc.; Atopic Dermatitis...TerminatedAtopic Dermatitis (AD)United States
-
Arcutis Biotherapeutics, Inc.Active, not recruitingAtopic Dermatitis EczemaUnited States, Canada
-
Numab Therapeutics AGKaken Pharmaceutical Co., Ltd.RecruitingAtopic DermatitisGermany, Canada, United States, Poland
-
HanAll BioPharma Co., Ltd.CompletedMild to Moderate Atopic DermatitisUnited States
-
Arcutis Biotherapeutics, Inc.CompletedAtopic Dermatitis EczemaUnited States, Canada
-
Columbia UniversitySociety for Pediatric DermatologyCompleted
-
Rockefeller UniversityIcahn School of Medicine at Mount SinaiCompletedAtopic DermatitisUnited States
-
Frankel, Amylynne, M.D.Onset Therapeutics, IncCompletedEczema | Atopic DermatitisUnited States
-
Emer, Jason, M.D.Ferndale LaboratoriesCompletedAtopic DermatitisUnited States
-
AOBiome LLCVeristat, Inc.CompletedAtopic Dermatitis EczemaUnited States
-
AmgenActive, not recruiting
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
PfizerCompleted
-
Icahn School of Medicine at Mount SinaiNovartisCompleted
-
Columbia UniversityCompletedAtopic DermatitisUnited States
-
Rockefeller UniversityCompletedEczema | Atopic DermatitisUnited States
-
Ralexar Therapeutics, Inc.CompletedAtopic Dermatitis | Eczema, AtopicUnited States
-
Icahn School of Medicine at Mount SinaiCompletedAtopic DermatitisUnited States
-
AmgenActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic DermatitisUnited States, Canada
-
DermTechRecruitingAtopic DermatitisUnited States
-
University of RochesterNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)WithdrawnAtopic DermatitisUnited States
-
Fougera Pharmaceuticals Inc.Completed
-
Aclaris Therapeutics, Inc.CompletedAtopic DermatitisUnited States
-
Evommune, Inc.CompletedAtopic Dermatitis EczemaUnited States
-
SanofiRegeneron PharmaceuticalsRecruitingModerate to Severe Atopic DermatitisCanada
-
Xantho Biotechnology Co., LTDVirginia Contract Research Organization Co., Ltd.Recruiting
-
Taro Pharmaceuticals USACompletedAtopic DermatitisUnited States
-
Yale UniversityCompletedAtopic DermatitisUnited States
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedModerate to Severe Atopic DermatitisUnited States, Canada, Czechia, Germany, Poland
-
Biosion, Inc.Southern Star Research Pty Ltd.CompletedAtopic DermatitisAustralia
-
Hoth Therapeutics, Inc.Novotech (Australia) Pty LimitedCompleted
-
Rutgers, The State University of New JerseyTerminatedAtopic DermatitisUnited States